NR1H3 and clear cell renal carcinoma: revealed that the anticancer effect of celastrol in renal clear cell carcinoma is caused by the activation of LXRα signalling to trigger autophagy and LD degradation, which then promotes ABCA1-mediated cholesterol efflux and impairs EMT progression.